Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/1991
05/21/1991US5017564 Solid pharmaceutical preparation and method of producing same
05/21/1991US5017379 Time-release, immunology
05/21/1991US5017366 Sunscreen, erythromycin
05/21/1991US5017229 Water insoluble derivatives of hyaluronic acid
05/21/1991CA2030029A1 Emulsified composition
05/17/1991CA2030006A1 Anhydrous pharmaceutical formulations and dosage forms for the rectal administration of calcitonin
05/17/1991CA2029929A1 Compounds to be used as carriers for active chemical, physical or biological products or other substances
05/16/1991WO1991006866A2 Urinary tumor associated antigen, antigenic subunits uses and methods of detection
05/16/1991WO1991006309A1 Method of in vivo delivery of functioning foreign genes
05/16/1991WO1991006290A1 Bioadhesive composition and patch
05/16/1991WO1991006289A1 Mucoadhesive carrier for delivery of therapeutical agent
05/16/1991WO1991006283A1 Tissue moisturizing composition and method
05/16/1991DE4035442A1 Medicament contg. r- or s- alpha-lipoic acid
05/16/1991DE3938030A1 Verfahren zur herstellung waessriger mischmicelloesungen A process for the preparation of aqueous mixed micelle
05/16/1991CA2029997A1 Polymyxin conjugates
05/16/1991CA2029940A1 Use of new injectable biodegradable microspheres, process for preparation thereof and injectable suspension comprising them
05/15/1991EP0427247A2 Pharmaceutical composition with R-alpha-lipoic acid or S-alpha-lipoic acid as the active ingredient
05/15/1991EP0427185A2 Copolymers from trimethylenecarbonate and optically inactive lactides
05/15/1991EP0427157A2 Endermic medicament with a gel base
05/15/1991EP0427078A1 Folinic acid-cyclodextrin inclusion compound
05/15/1991EP0426974A2 Composition containing acetaminophen
05/15/1991EP0261234B1 Dual phase solvent carrier system
05/15/1991EP0259468B1 Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
05/15/1991CN1051389A Novel antibodies reactive with human carcinomas
05/15/1991CN1051367A Yttrium and rare earth compounds catalyzed lactone polymerization
05/14/1991WO1991007418A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
05/14/1991WO1991007182A1 rRNA SPECIFIC OLIGONUCLEOTIDES
05/14/1991WO1991007171A1 Lipospheres for controlled delivery of substances
05/14/1991US5015632 Germicides for skins
05/14/1991US5015627 Stabilized somatotropin for parenteral administration
05/14/1991US5015481 Stabilized pharmaceutical admixture composition
05/14/1991US5015479 Sustained release capsule or tablet formulation comprising a pharmaceutically acceptable dihydropyridine
05/14/1991US5015474 Yerba santa extract for topical application or vaginal douche
05/14/1991CA2068325A1 Rrna specific oligonucleotides
05/14/1991CA2044590A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
05/11/1991CA2029667A1 Process
05/09/1991CA2028354A1 Substantially anhydrous complexes of pvp and h o
05/08/1991WO1991006288A1 A nicotine containing stimulant unit
05/08/1991EP0426463A2 Method of encapsulating biologically active substances, a capsule produced by the method, its use, and a fodder containing such capsules
05/08/1991EP0426434A1 Sugar beet pectins and their use in comestibles
05/08/1991EP0426055A2 Copolymers from lactic acid and tartaric acid, their preparation and their use
05/08/1991EP0426029A1 Injectable formulation for lipophilic drugs
05/08/1991EP0425968A2 Novel multiple layer transdermal drug administration system
05/08/1991EP0425639A1 Plant protecting preparations, veterinary and additive preparations.
05/08/1991EP0425505A1 Transdermal antisecretory agents for gastrointestinal disease.
05/08/1991EP0374252A4 Injection-type hemostatic composition
05/08/1991EP0362321A4 Ophthalmic suspensions
05/07/1991WO1991006287A1 Protein microspheres and methods of using them
05/07/1991WO1991006286A1 Method for producing protein microspheres
05/07/1991US5013868 Process for treating amphoteric amino acids
05/07/1991US5013855 Reacting a 3-halo-1,2-propanediol sulfate with a phenol in the presence of base
05/07/1991US5013747 Water-soluble antiseptic or antifungal composition
05/07/1991US5013728 Composition for treating osteoporosis and hormonal imbalance
05/07/1991US5013726 External analgesic lotion containing active ingredients of methyl salicylate and camphor and menthol and method of making such lotion
05/07/1991US5013716 Flavor with chlorodeoxysugars, medicines
05/07/1991US5013715 Polymethylphenylsiloxane And A Saccharose Fatty Acid Ester; Cosmetic and Medicinal Uses
05/07/1991US5013713 Prolonged release of biologically active somatotropin
05/07/1991US5013556 Lipids derivatized with polyoxyethylene glycol, drug delivery, antitumor agents
05/07/1991US5013554 Administering antitussive dextrorphan citrate
05/07/1991US5013547 Anticancer drug - antibody conjugates and method for preparing same
05/07/1991US5013545 Ethanol, antihistamine
05/07/1991US5013541 Poly(alpha-hydroxy acrylic acid) and derivatives as antitartar actives in oral compositions
05/07/1991CA2071867A1 Method for producing protein microspheres
05/07/1991CA1283998C Coatable ion exchange resins
05/05/1991WO1991006282A1 Small particle drug compositions
05/04/1991CA2331088A1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection
05/03/1991WO1991006322A1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier
05/03/1991CA2045504A1 Magnetically controlled carrier with physiologically active agent and process for preparing thereof
05/02/1991WO1991005795A1 Stem cell factor
05/02/1991WO1991005605A1 Cyclodextrin labels for immunoassay and biochemical analysis
05/02/1991WO1991005544A1 Drug delivery system, method for preparing the same, and use thereof
05/02/1991WO1991005529A1 Drug delivery systems and matrix therefor
05/02/1991EP0425443A1 Injectable antiparasitic agent
05/02/1991EP0425373A1 Pharmaceutical and cosmetic composition containing cross-linked poly-beta-alamine spheres impregnated by lipophilic substances
05/02/1991EP0425298A2 Sustained-release preparation of basic medical agent hydrochloride
05/02/1991EP0425268A2 Phosphazene polymer carrier for biologically active substance
05/02/1991EP0425235A2 Cytotoxic agents comprising maytansinoids and their therapeutic use
05/02/1991EP0425154A1 Sustained release elements
05/02/1991EP0425023A2 Cellulosic coating
05/02/1991EP0424679A2 Protection of a food product, a cosmetic product or a pharmaceutical product against oxydation
05/02/1991EP0424386A1 Device for site directed neovascularization and method for same
05/02/1991DE3938227C1 Oral antiinflammatory and analgetic pharmaceutical compsn. - comprises magnesium ibuprofen dissolved in mixt. of water, propane-1,2-diol and glycerol
05/02/1991CA2029022A1 Sugar beet pectins and their use in comestibles
05/01/1991WO1991006310A1 Liposomal compositions
05/01/1991CN1050987A Stable immunogen composition for oral administration
05/01/1991CA2066698A1 Liposomal compositions
05/01/1991CA2028604A1 Injectable formulation for lipophilic drugs
04/1991
04/30/1991US5011913 Complexing with technetium; scanning agents, medical diagnosis
04/30/1991US5011855 Oil extracted from pips of Ribes genus fruits
04/30/1991US5011852 Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
04/30/1991US5011694 Exposing matrix of compressed mixture of powdered drug and polymer to vapor of lower alcohol
04/30/1991US5011693 Haemostatic agents
04/30/1991US5011686 Injectable reagent with affinity for fibrin
04/30/1991US5011678 Suspension of biocompatible polypeptide drug, steroid and fluorocarbon propellant; for mucosal area; antidiabetic, osteoporosis, Paget*s disease; sodium tauro-24,25-dihydro-fusidate
04/30/1991US5011677 For radiation therapy
04/30/1991US5010685 Encapsulated in mixture of ethylene-vinyl acetate copolymer and wax matrices
04/30/1991CA1283750C Platinum co-ordination compounds
04/30/1991CA1283661C Imidazolides, process for their preparation and application as intermediates for the synthesis of cytotoxic conjugates
04/30/1991CA1283655C Acid decrystallization of aminopolysaccharides and derivatives thereof
04/30/1991CA1283607C Stable injectable pharmaceutical formulation for 1,4- dihydroxy-5-8-bis¬2-(2-hydroxyethylamino)-ethylamino| anthraquinone, dihydrochloride